European Archives - Page 230 of 1108 - European Medical Journal

Monoclonal Gammopathy of Undetermined Significance: Is Bone Marrow Sampling Needed?

A new multivariable model can predict smouldering multiple myeloma in patients with monoclonal gammopathy of undetermined significance, according to recent research.

Proliferative Lupus Nephritis with Focal Extracapillary Proliferation in Latin America

This study investigates the impact of extracapillary proliferation in proliferative lupus nephritis on remission rates in patients.

No Bolusing with Closed Loop

This article reviews real-world data presented at the ADA Scientific Sessions 2024. It demonstrates the glycaemic range when Control-IQ Technology users do not manually bolus for extended periods

Interview: Rick Abramson

I have worked previously in healthcare management consulting, health services research, clinical practice, and healthcare administration…

Genomic Determinants of Relapse in Childhood Acute Lymphoblastic Leukaemia

A study has shed light on the genomic factors contributing to relapse in children with acute lymphoblastic leukaemia, the most common childhood tumour.

Uterus Transplants Associated with High Live Birth Rate

Uterus transplant may be feasible and safe for a select group of women with uterine factor infertility.

Severe Menopause Increases Risk of Cognitive Impairment

Severe menopausal symptoms in post-menopausal women have been associated with cognitive impairment according to results of a study.

High Urinary Calcium and Oxalate Levels Linked to Kidney Stones

Adults with elevated levels of calcium and oxalate in their urine may be at a heightened risk for developing kidney stones, according to a new study.

Lung Matters: Understanding COPD

Jean Wright, CEO of the COPD Foundation, joins Jonathan Sackier to discuss her transformative journey in healthcare and innovative approaches to managing chronic lung diseases.

NHS must adapt for next wave of advanced therapies, warns ABPI

The NHS has made commendable progress in introducing advanced therapies, but it must accelerate preparations for the next wave.